ITGAM

Integrin alpha-M · P11215 · ITGAM on Sugi Atlas →

2,188 patent compounds predicted against ITGAM, 1,419 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL46558 SCHEMBL46558 1.00 7/20
SCHEMBL46561 SCHEMBL46561 1.00 7/20
SCHEMBL684267 SCHEMBL684267 0.82 7/20
SCHEMBL5142920 SCHEMBL5142920 0.79 7/20
SCHEMBL5142921 SCHEMBL5142921 0.79 7/20
SCHEMBL46549 SCHEMBL46549 0.63 7/20
SCHEMBL46465 SCHEMBL46465 1.00 6/20
SCHEMBL683059 SCHEMBL683059 1.00 6/20
SCHEMBL684265 SCHEMBL684265 1.00 6/20
SCHEMBL46217 SCHEMBL46217 0.80 6/20
SCHEMBL684060 SCHEMBL684060 0.80 6/20
SCHEMBL5167082 SCHEMBL5167082 0.77 6/20
SCHEMBL5167090 SCHEMBL5167090 0.77 6/20
SCHEMBL5145053 SCHEMBL5145053 0.74 6/20
SCHEMBL5145055 SCHEMBL5145055 0.74 6/20
SCHEMBL46469 SCHEMBL46469 0.74 6/20
SCHEMBL46467 SCHEMBL46467 0.74 6/20
SCHEMBL5147227 SCHEMBL5147227 0.73 6/20
SCHEMBL5147232 SCHEMBL5147232 0.73 6/20
SCHEMBL5166105 SCHEMBL5166105 0.68 6/20

Clinical trials — most relevant to ITGAM by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer PHASE1/PHASE2COMPLETED
68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Angiogenesis in Ischemic Heart Disease PHASE2UNKNOWN
A Gene Therapy Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I PHASE1WITHDRAWN
Cigarette Smoke Nasal and Whole Blood Challenge in Patients With Chronic Obstructive Pulmonary Disease (COPD) PHASE1COMPLETED
Vedolizumab (Anti-alpha4beta7) in Subjects With HIV Infection Undergoing Analytical Treatment Interruption PHASE1COMPLETED
Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6 PHASE1RECRUITING
Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors PHASE1COMPLETED
68Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid Arthritis EARLY_PHASE1UNKNOWN
68Ga-NOTA-PRGD2 PET/CT in Patients With Lung Injury and Pulmonary Fibrosis EARLY_PHASE1UNKNOWN
68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Stroke EARLY_PHASE1UNKNOWN
68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma EARLY_PHASE1UNKNOWN
68Ga-BNOTA-PRGD2 PET/CT in Healthy Volunteers and Lung Cancer Patients EARLY_PHASE1UNKNOWN
Safety and Efficacy of ONT01 in Lupus EARLY_PHASE1RECRUITING
99mTc-3PRGD2 SPECT/CT in Rheumatoid Arthritis Patients EARLY_PHASE1COMPLETED
Angiogenesis and Fibrosis in Aortic Stenosis nanCOMPLETED
Angiogenesis and Fibrosis in Myocardial Infarction nanCOMPLETED
Anti-αIIbβ3 Immunization in Glanzmann Thrombasthenia: Prevalence and Associated Risk Factors: Thrombasthenia Anti-αIIbβ3 Antibodies Study (TAAS) nanCOMPLETED
Role of CD11a in Pathogenesis of Primary ITP and Effect of Immunosuppressive Therapy on Its Level nanCOMPLETED
The Role of CD4+ T Cell Subsets in the Mechanism of Action of Vedolizumab in Ulcerative Colitis nanUNKNOWN
CancerenD24 Screening as an Aid to the Clinician for the Diagnosis of Cancer nanRECRUITING
Clinical Study of 18F-FAPI-RGD in Ovarian Cancer nanCOMPLETED
IMaging Pilot Study of the αvβ6 Integrin Radiotracer [18F]-A20FMDV2 in PAtients With Solid Cancer Types nanCOMPLETED
Cd11b and Cd56 as Prognostic Markers in Acute Myeloid Leukemia nanUNKNOWN
The Role of Platelet Surface α2β1 Integrin Expression as a Risk Factor in Thrombotic and/or Bleeding Complications nanCOMPLETED
Potential Role of microRNA 410 and BIRC7 Pathways in Recurrent Spontaneous Miscarriage nanCOMPLETED
ITGA2b and SELP Expression in Cancer Pancreas and Biliary Tract Cancer nanUNKNOWN
T Lymphocyte Subsets in Ulcerative Colitis nanNOT_YET_RECRUITING
Clinical Pattern of Glanzemnn Thrombathenia in Children Attending Assiut University Children Hospital nanNOT_YET_RECRUITING
Eosinophil β1 Integrin Activation as a Biomarker for Eosinophilic Esophagitis nanCOMPLETED
The Role of the Novel 99mTc-NC100692 Tracer in Patients at High Risk or Known Breast Cancer nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a ITGAM binder may also engage these)

ProteinNameSimilarity
Q3V0T4 1.000 Q3V0T4 →
P05555 1.000 P05555 →
Q13349 1.000 Q13349 →
Q9QXH4 0.998 Q9QXH4 →
ITGAL Integrin alpha-L 0.998 landscape →
P20702 0.997 P20702 →
P38570 0.997 P38570 →
Q62469 0.996 Q62469 →
Q9QYE7 0.996 Q9QYE7 →
P24063 0.992 P24063 →
P61625 0.991 P61625 →
O75578 0.990 O75578 →
P61622 0.989 P61622 →
E1BFX5 0.987 E1BFX5 →
ITGA2 Integrin alpha-2 0.986 landscape →
Q60677 0.985 Q60677 →
Q9UKX5 0.985 Q9UKX5 →
Q62470 0.984 Q62470 →
P11688 0.984 P11688 →
P26006 0.983 P26006 →
P53710 0.983 P53710 →
F1MMS9 0.982 F1MMS9 →
B8JK39 0.981 B8JK39 →
Q13797 0.980 Q13797 →
ITGA5 Integrin alpha-5 0.980 landscape →
ITGA2B Integrin alpha-IIb 0.980 landscape →
Q13683 0.979 Q13683 →
P17852 0.977 P17852 →
ITGA8 Integrin alpha-8 [Cleaved into: Integrin alph 0.977 landscape →
Q63258 0.975 Q63258 →